CD301b lectin expression in the breast tumor microenvironment augments tumor growth
preprint
OA: closed
CC-BY-4.0
Abstract
Abstract Aberrant tumor glycosylation can alter immune recognition; however, the specific influence of glycan-lectin interactions on tumor progression remains poorly understood. Here, we identify the C-type lectin receptor CD301b (encoded by Mgl2 ) as a regulator of immune activity within the breast tumor microenvironment (TME). Using a murine triple-negative breast cancer model, we demonstrate that tumors expressing the Tn glycoantigen grow more rapidly, and this growth is facilitated by CD301b⁺ immune cells. Depletion or genetic loss of CD301b markedly suppressed tumor growth, indicating that CD301b promotes tumor progression through myeloid-tumor interactions. Phenotypic analyses revealed that CD301b⁺ cells within tumors are type 2 conventional dendritic cells (cDC2s), a subset known to influence immune polarization. Single-cell RNA sequencing of human breast cancers showed that the human ortholog CLEC10A is expressed in cDC2-like dendritic cells and select macrophage subsets, suggesting a conserved role for CD301⁺ myeloid populations. Transcriptomic profiling of tumors developed in Mgl2 -deficient mice revealed a shift toward an inflammatory, immune-activated state consistent with enhanced antitumor immunity. Together, these findings establish a link between tumor glycosylation and lectin signaling of myeloid cells, highlighting CD301b as a potential target for reprogramming the tumor immune microenvironment in breast cancer.
Full text
19,259 characters
· extracted from
preprint-html
· click to expand
CD301b lectin expression in the breast tumor microenvironment augments tumor growth | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article CD301b lectin expression in the breast tumor microenvironment augments tumor growth Ahmet Ozdilek, Amy V. Paschall, Zahra Nawaz, Afaq M. M. Niyas, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8148605/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Aberrant tumor glycosylation can alter immune recognition; however, the specific influence of glycan-lectin interactions on tumor progression remains poorly understood. Here, we identify the C-type lectin receptor CD301b (encoded by Mgl2 ) as a regulator of immune activity within the breast tumor microenvironment (TME). Using a murine triple-negative breast cancer model, we demonstrate that tumors expressing the Tn glycoantigen grow more rapidly, and this growth is facilitated by CD301b⁺ immune cells. Depletion or genetic loss of CD301b markedly suppressed tumor growth, indicating that CD301b promotes tumor progression through myeloid-tumor interactions. Phenotypic analyses revealed that CD301b⁺ cells within tumors are type 2 conventional dendritic cells (cDC2s), a subset known to influence immune polarization. Single-cell RNA sequencing of human breast cancers showed that the human ortholog CLEC10A is expressed in cDC2-like dendritic cells and select macrophage subsets, suggesting a conserved role for CD301⁺ myeloid populations. Transcriptomic profiling of tumors developed in Mgl2 -deficient mice revealed a shift toward an inflammatory, immune-activated state consistent with enhanced antitumor immunity. Together, these findings establish a link between tumor glycosylation and lectin signaling of myeloid cells, highlighting CD301b as a potential target for reprogramming the tumor immune microenvironment in breast cancer. Biological sciences/Cancer Biological sciences/Computational biology and bioinformatics Biological sciences/Immunology Health sciences/Oncology Full Text Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8148605","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":554050584,"identity":"c5c5c0c9-6d7f-40d9-a133-de2f412939a8","order_by":0,"name":"Ahmet Ozdilek","email":"","orcid":"","institution":"Emory University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Ahmet","middleName":"","lastName":"Ozdilek","suffix":""},{"id":554050585,"identity":"faf5674e-71e1-4d17-8f0f-9e0f0ca41aa8","order_by":1,"name":"Amy V. Paschall","email":"","orcid":"","institution":"Emory University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Amy","middleName":"V.","lastName":"Paschall","suffix":""},{"id":554050586,"identity":"7d83f326-f9fe-49c6-8500-a11bf58bfe28","order_by":2,"name":"Zahra Nawaz","email":"","orcid":"","institution":"Emory University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Zahra","middleName":"","lastName":"Nawaz","suffix":""},{"id":554050587,"identity":"5e5dabcd-e1f0-41f8-8437-4960123c263c","order_by":3,"name":"Afaq M. M. Niyas","email":"","orcid":"","institution":"Emory University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Afaq","middleName":"M. M.","lastName":"Niyas","suffix":""},{"id":554050588,"identity":"7a8aaf79-43b6-457a-ae3d-8fd842c0836f","order_by":4,"name":"Fikri Y. Avci","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAsUlEQVRIiWNgGAWjYBAC9gYgkVAB47IRoYXnAEjLGZK1MLaRpIX9jOGHh/NsovmlzxgwfCg7TIQWnhxjicRtabkz+3IMGGecI0KLPUNaGkPitsO5G87wGDDzthFjC/8zoJY5/yFa/hKlRSL5GENiwwGIFkbitDw+LJFwLDl3Zg9bwcGec+nEOCyx8eOPGrvcfh7mjQ9+lFkT1oIEOAwOkKQeCNgfkKpjFIyCUTAKRggAAIRbORX6+0gGAAAAAElFTkSuQmCC","orcid":"","institution":"Emory University School of Medicine","correspondingAuthor":true,"prefix":"","firstName":"Fikri","middleName":"Y.","lastName":"Avci","suffix":""}],"badges":[],"createdAt":"2025-11-18 19:23:21","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8148605/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8148605/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":97322703,"identity":"5c26a485-3e0e-4344-b05d-efe07d48a8fb","added_by":"auto","created_at":"2025-12-03 08:09:25","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":2223456,"visible":true,"origin":"","legend":"","description":"","filename":"BCmanuscript112025withFigures.docx","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/9f932bfccd725be6ef068d89.docx"},{"id":97322697,"identity":"c40a3259-677f-4d60-93db-13deaf8904f4","added_by":"auto","created_at":"2025-12-03 08:09:24","extension":"json","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":6888,"visible":true,"origin":"","legend":"","description":"","filename":"6145f4df8a294ea28b8f4cc47a486281.json","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/aa0b92713918129dec11ba45.json"},{"id":97322698,"identity":"a5e96847-3a3d-4e8b-b2be-af1c84621512","added_by":"auto","created_at":"2025-12-03 08:09:24","extension":"xml","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":170447,"visible":true,"origin":"","legend":"","description":"","filename":"6145f4df8a294ea28b8f4cc47a4862811enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/49365025cd33bb54d91c5f88.xml"},{"id":97322725,"identity":"e4c675f4-f3b1-443d-8711-60f578faff7f","added_by":"auto","created_at":"2025-12-03 08:09:33","extension":"jpeg","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":1619522,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage1.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/466d46e9f4dbce7a9be0736d.jpeg"},{"id":97322713,"identity":"c347757d-cd76-45b9-89d2-a3bfea4ffadc","added_by":"auto","created_at":"2025-12-03 08:09:26","extension":"jpeg","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":1833337,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage2.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/9b693cee825c630ca2278ed6.jpeg"},{"id":97322715,"identity":"6b62bfbd-b878-48e0-8de1-b3cfbf64bc5d","added_by":"auto","created_at":"2025-12-03 08:09:26","extension":"png","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":68693,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/db71deaea202831c9ce70eb4.png"},{"id":97322717,"identity":"2652e3be-e449-48db-be09-c774c7d25f9e","added_by":"auto","created_at":"2025-12-03 08:09:28","extension":"png","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":301589,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/56b072f84de65efce04836a0.png"},{"id":97322702,"identity":"d838055c-dbab-4d6d-b37e-bd6853f41ab7","added_by":"auto","created_at":"2025-12-03 08:09:25","extension":"png","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":187625,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage5.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/ca2fc2b7ba1ec0e8fb2fc1c6.png"},{"id":97322690,"identity":"f494f080-6041-498e-9f0f-d7a85e18e162","added_by":"auto","created_at":"2025-12-03 08:09:23","extension":"jpeg","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":126246,"visible":true,"origin":"","legend":"","description":"","filename":"groupimage1.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/22931c509ab4008f847d22a8.jpeg"},{"id":97322706,"identity":"14be1db7-5586-4cdf-a4ab-9b02a1f9bfcf","added_by":"auto","created_at":"2025-12-03 08:09:25","extension":"jpeg","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":103342,"visible":true,"origin":"","legend":"","description":"","filename":"groupimage2.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/8dcd48ed59b305502e6b39ad.jpeg"},{"id":97322694,"identity":"835284b2-e210-4472-8c43-39904d47c876","added_by":"auto","created_at":"2025-12-03 08:09:24","extension":"png","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":290102,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/5f63e26389715ebb60887a42.png"},{"id":97322700,"identity":"bfaf6454-26d8-4f20-9e73-63371a2ac469","added_by":"auto","created_at":"2025-12-03 08:09:24","extension":"png","order_by":11,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":281889,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/1ca6d2e6d0a157ff37ac8342.png"},{"id":97322701,"identity":"7ee3352b-0bc5-4d1f-bd60-65b31493a001","added_by":"auto","created_at":"2025-12-03 08:09:24","extension":"png","order_by":12,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":18405,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/04539d232aeeaeea6b411be1.png"},{"id":97322724,"identity":"cfdd101a-7199-47f4-8671-a1ffbc0a74bd","added_by":"auto","created_at":"2025-12-03 08:09:32","extension":"png","order_by":13,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":153510,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/75b5e068d27673ab318ed176.png"},{"id":97322710,"identity":"e5c2ec44-002c-4cd2-9f92-466118b8f824","added_by":"auto","created_at":"2025-12-03 08:09:26","extension":"png","order_by":14,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":56209,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage5.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/0336cb7c19ce1fc507ffb9a5.png"},{"id":97322723,"identity":"06573642-3ae6-433c-9371-ee8fbbdbcd1e","added_by":"auto","created_at":"2025-12-03 08:09:32","extension":"png","order_by":15,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":31989,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinegroupimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/dcb6020875b4db4e20d632fa.png"},{"id":97322708,"identity":"280634fa-3e26-4c11-aa09-29894b9185de","added_by":"auto","created_at":"2025-12-03 08:09:25","extension":"png","order_by":16,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":32949,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinegroupimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/22754dc02dfa03ff978f7523.png"},{"id":97322709,"identity":"e2e499e6-9557-4630-a1bc-3b80eca92f6c","added_by":"auto","created_at":"2025-12-03 08:09:26","extension":"xml","order_by":17,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":168934,"visible":true,"origin":"","legend":"","description":"","filename":"6145f4df8a294ea28b8f4cc47a4862811structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/09f2b7330b5a4846e5e1339b.xml"},{"id":97322704,"identity":"279490f7-5fba-4622-8d5a-3085f53f6bb4","added_by":"auto","created_at":"2025-12-03 08:09:25","extension":"html","order_by":18,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":183967,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1/4bc8111aa5ae1ab6b17ea857.html"},{"id":100365960,"identity":"ee1cc391-06f6-4c12-aefc-f848ce149fe5","added_by":"auto","created_at":"2026-01-16 07:55:47","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1507354,"visible":true,"origin":"","legend":"","description":"","filename":"BCmanuscript112025withFigures.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8148605/v1_covered_2120c679-53f5-43b8-b7e2-eb9e591ed8ac.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"CD301b lectin expression in the breast tumor microenvironment augments tumor growth","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-8148605/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8148605/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eAberrant tumor glycosylation can alter immune recognition; however, the specific influence of glycan-lectin interactions on tumor progression remains poorly understood. Here, we identify the C-type lectin receptor CD301b (encoded by \u003cem\u003eMgl2\u003c/em\u003e) as a regulator of immune activity within the breast tumor microenvironment (TME). Using a murine triple-negative breast cancer model, we demonstrate that tumors expressing the Tn glycoantigen grow more rapidly, and this growth is facilitated by CD301b⁺ immune cells. Depletion or genetic loss of CD301b markedly suppressed tumor growth, indicating that CD301b promotes tumor progression through myeloid-tumor interactions. Phenotypic analyses revealed that CD301b⁺ cells within tumors are type 2 conventional dendritic cells (cDC2s), a subset known to influence immune polarization. Single-cell RNA sequencing of human breast cancers showed that the human ortholog CLEC10A is expressed in cDC2-like dendritic cells and select macrophage subsets, suggesting a conserved role for CD301⁺ myeloid populations. Transcriptomic profiling of tumors developed in \u003cem\u003eMgl2\u003c/em\u003e-deficient mice revealed a shift toward an inflammatory, immune-activated state consistent with enhanced antitumor immunity. Together, these findings establish a link between tumor glycosylation and lectin signaling of myeloid cells, highlighting CD301b as a potential target for reprogramming the tumor immune microenvironment in breast cancer.\u003c/p\u003e","manuscriptTitle":"CD301b lectin expression in the breast tumor microenvironment augments tumor growth","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-12-03 08:09:02","doi":"10.21203/rs.3.rs-8148605/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"1bf43d9d-8c1a-43a0-975e-b63ae5bef0c5","owner":[],"postedDate":"December 3rd, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":58957228,"name":"Biological sciences/Cancer"},{"id":58957229,"name":"Biological sciences/Computational biology and bioinformatics"},{"id":58957230,"name":"Biological sciences/Immunology"},{"id":58957231,"name":"Health sciences/Oncology"}],"tags":[],"updatedAt":"2026-01-13T01:08:38+00:00","versionOfRecord":[],"versionCreatedAt":"2025-12-03 08:09:02","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8148605","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8148605","identity":"rs-8148605","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (82)
- The Cosmc connection to the Tn antigen in cancer. via crossref
- doi:10.1007/978-3-319-70197-4_10 via crossref
- doi:10.1084/jem.170.6.2081 via crossref
- doi:10.1371/journal.pcbi.1003470 via crossref
- doi:10.1084/jem.192.7.1027 via crossref
- doi:10.1136/jitc-2020-001222 via crossref
- doi:10.1007/s00018-019-03288-x via crossref
- doi:10.1038/nrc3982 via crossref
- doi:10.1038/s41573-023-00636-2 via crossref
- doi:10.1073/pnas.2102950118 via crossref
- doi:10.1038/ni.3552 via crossref
- doi:10.1158/0008-5472.can-04-1921 via crossref
- doi:10.1158/0008-5472.can-15-2834 via crossref
- doi:10.1074/jbc.m110.209742 via crossref
- doi:10.1007/s00262-006-0274-z via crossref
- doi:10.1038/ni1390 via crossref
- doi:10.1158/1078-0432.ccr-09-0737 via crossref
- doi:10.1093/glycob/cwad083 via crossref
- doi:10.1073/pnas.0914004107 via crossref
- doi:10.1371/journal.pone.0125994 via crossref
- doi:10.2217/imt.10.17 via crossref
- doi:10.1016/j.humpath.2013.04.010 via crossref
- doi:10.1042/bst20170483 via crossref
- doi:10.1046/j.1365-2567.2003.01656.x via crossref
- doi:10.1016/j.vaccine.2006.11.007 via crossref
- doi:10.1073/pnas.1115166109 via crossref
- doi:10.3390/biom5031783 via crossref
- doi:10.3389/fimmu.2017.00264 via crossref
- doi:10.1016/j.molimm.2008.11.021 via crossref
- doi:10.7554/elife.17979 via crossref
- doi:10.1016/j.immuni.2013.08.029 via crossref
- doi:10.1158/0008-5472.can-16-2212 via crossref
- doi:10.1016/j.canlet.2021.06.012 via crossref
- doi:10.1073/pnas.262438199 via crossref
- doi:10.1093/glycob/cwz095 via crossref
- doi:10.1038/s41590-022-01218-x via crossref
- doi:10.1371/journal.pone.0005619 via crossref
- doi:10.1038/s41467-021-25307-x via crossref
- doi:10.1016/j.trecan.2018.09.001 via crossref
- doi:10.1016/j.immuni.2012.04.012 via crossref
- doi:10.1186/s13062-023-00430-5 via crossref
- doi:10.3390/cancers14081976 via crossref
- doi:10.15252/embj.2020107333 via crossref
- doi:10.1016/j.it.2004.09.015 via crossref
- doi:10.1136/jitc-2023-007441 via crossref
- doi:10.1186/s13059-020-02222-w via crossref
- doi:10.3389/fimmu.2021.756722 via crossref
- doi:10.1007/s00262-022-03357-4 via crossref
- doi:10.1084/jem.20161707 via crossref
- doi:10.1038/s41401-024-01381-x via crossref
- doi:10.1038/nature07205 via crossref
- doi:10.1016/j.cell.2010.01.025 via crossref
- doi:10.1038/sigtrans.2017.23 via crossref
- doi:10.1038/cmi.2010.27 via crossref
- doi:10.1038/nature07201 via crossref
- doi:10.1038/onc.2017.63 via crossref
- doi:10.1016/j.ajpath.2012.08.044 via crossref
- doi:10.1016/j.gene.2022.146564 via crossref
- doi:10.1186/1756-9966-29-135 via crossref
- doi:10.1074/jbc.272.39.24198 via crossref
- doi:10.1186/s12943-015-0386-1 via crossref
- doi:10.1371/journal.pone.0072413 via crossref
- doi:10.1126/science.abi5200 via crossref
- doi:10.1038/s41568-020-0285-7 via crossref
- doi:10.1016/j.immuni.2018.03.023 via crossref
- doi:10.1080/14728222.2024.2374743 via crossref
- doi:10.1038/nri.2016.55 via crossref
- doi:10.1038/ni.1937 via crossref
- doi:10.1158/0008-5472.can-15-1737 via crossref
- doi:10.1038/s41568-020-0273-y via crossref
- doi:10.1038/nri3737 via crossref
- doi:10.1038/s41587-019-0201-4 via crossref
- doi:10.1093/bioinformatics/btt656 via crossref
- doi:10.1186/s13059-014-0550-8 via crossref
- doi:10.1038/s41596-024-01020-z via crossref
- doi:10.1093/nar/30.1.207 via crossref
- doi:10.1038/s41587-023-01767-y via crossref
- doi:10.1016/j.cels.2019.03.003 via crossref
- doi:10.1038/s41467-023-37353-8 via crossref
- doi:10.1093/nar/gkac947 via crossref
- doi:10.1038/s41423-020-0488-6 via crossref
- doi:10.1016/j.cell.2021.01.010 via crossref
Source provenance
- crossref
- last seen: 2026-07-01T06:30:51.530633+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0